AOD 9604
HGH Fragment 177-191 analog
Fat-burning fragment of HGH.
Mechanism of Action
Stimulates lipolysis without affecting blood sugar.
Key Benefits
- Targeted abdominal fat loss
Common Uses
What to Expect
Onset
Subtle fat-loss effects begin at 2–4 weeks; most visible results at 6–8 weeks
Duration
Best results over a full 8–12 week cycle; works gradually rather than dramatically
What Users Report
- Gradual reduction in stubborn fat areas, especially around the abdomen and love handles
- Effects are subtle and build slowly — not an overnight transformation but a steady trend
- No energy crashes, jitteriness, or stimulant-like feelings — it works quietly in the background
- No impact on blood sugar or insulin levels, making it suitable alongside other protocols
- Works best when combined with consistent exercise and a calorie-controlled diet
- Often described as 'nudging' stubborn fat that diet and exercise alone couldn't touch
- Some users report mild improvement in joint comfort as a secondary benefit
Typical Timeline
Weeks 1–2: No dramatic changes; the peptide is working at the cellular level. Weeks 2–4: First subtle changes — waistband may feel slightly looser. Weeks 4–8: Visible reduction in stubborn fat deposits; measurements improve. Weeks 8–12: Full cycle benefits; best results when paired with consistent training and nutrition.
Side Effects
- Minimal
Dosage Protocol
300–500 mcg subcutaneously daily (morning or pre-bed). Cycles: 8–12 weeks. Titrate from 300 mcg.
Always consult a physician before starting any peptide protocol.
Administration
Injection
FDA Status
Category 2 (potential reclassification 2026)
Stacks Well With
- Tesamorelin
Tags
Related peptides
Tesamorelin
GHRH analog for visceral fat.
CJC-1295 (with/without DAC)
Growth Hormone Releasing Hormone analog
Long-acting GH secretagogue.
Ipamorelin
Selective ghrelin mimetic – safest GH peptide.
Semaglutide
GLP-1 agonist
FDA-approved weight-loss powerhouse.